Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2005
05/19/2005US20050107369 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
05/19/2005US20050107365 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics
05/19/2005US20050107355 Agonists of the kappa opioid receptor for treating gastrointestinal disorders, pain, and pruritus; N-{2-[(S)-3-hydroxy-pyrrolidin-1-yl]-(S)-1-phenyl-ethyl}-N-methyl-2-phenylamino-acetamide
05/19/2005US20050103226 Anthraquinone dye and inkjet recording liquid
05/19/2005DE10348554A1 Verwendung einer Verbindung aus der Gruppe der Heterodiazole oder eines Salzes der Verbindung, die Verbindung oder das Salz enthaltende kosmetische oder therapeutische Formulierung, die Verbindung oder das Salz als therapeutisches Mittel sowie das Salz selbst Use of a compound from the group of heterodiazoles or a salt of the compound, the compound or the salt-containing cosmetic or therapeutic formulation, the compound or the salt as a therapeutic agent as well as the salt itself
05/19/2005CA2544748A1 Allosteric modulators of metabotropic glutamate receptors
05/19/2005CA2543199A1 Use of crth2 antagonist compounds in therapy
05/18/2005EP1531153A1 Epothilone derivatives
05/18/2005EP1530570A2 CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF
05/18/2005EP1530569A2 Pyridyl substituted heterocycles useful for treating or preventing hcv infection
05/18/2005EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
05/18/2005EP1530472A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
05/18/2005EP1224195B1 C-aryl glucoside sglt2 inhibitors
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005CN1617870A N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds
05/18/2005CN1617863A Thiadiazole compounds and use thereof
05/18/2005CN1617862A Novel 1, 2, 4-thiadiazole derivatives as melanocortin receptor modulators
05/18/2005CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament
05/18/2005CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617722A Nicotin-or isonicotin benzothiazole derivatives
05/18/2005CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof
05/18/2005CN1616439A Improved method for preparing thiazolidine-2, 4-diketo derivative
05/18/2005CN1616386A Intermediate for preparing isothiazole derivatives
05/18/2005CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202093C Substituted heterocyclic compound
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894171 Protease inhibitors; viricides; purity, crystal structure
05/17/2005US6894170 Process for the preparation of substituted thiazolines and their intermediates
05/17/2005US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases
05/17/2005US6894063 Drugs for treating metabolic and eating disorders, diabetes
05/17/2005US6894054 Central nervous system disorders; muscular disorders
05/17/2005US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/17/2005US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893859 Antiproliferative agent for treating diseases or conditions characterized by cellular hyperproliferation
05/17/2005US6893471 For dyeing human hair
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/17/2005CA2158057C Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides
05/17/2005CA2125549C Tetrazole derivatives, their production and use
05/12/2005WO2005042712A2 Heterocyclic compounds and methods of making and using thereof
05/12/2005WO2005042525A1 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
05/12/2005WO2005042524A1 Pyridine carboxamide and methods for inhibiting hiv integrase
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto
05/12/2005WO2005042505A1 Thiozolidinones, production and use thereof as medicaments
05/12/2005WO2005042502A1 Amide derivatives
05/12/2005WO2005042500A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005042496A1 (benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005041888A2 Pyrimidin-4-one compounds, compositions and methods
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005021519A3 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005009982A3 Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101782 Process for the preparation of substituted thiazolines and their intermediates
05/12/2005US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative
05/12/2005US20050101650 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101636 PPAR-activating compound and pharmaceutical composition comprising the compound
05/12/2005US20050101630 4-Anilino-, phenoxy-, or phenylthio-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
05/12/2005US20050101617 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
05/12/2005US20050101616 Quinazoline analogs as receptor tyrosine kinase inhibitors
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
05/12/2005US20050101595 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101586 Novel 5-HT2A receptor ligands
05/12/2005US20050101567 Using a sulfonamide containing compound
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2544267A1 Thiazolidinones, production and use thereof as medicaments
05/12/2005CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005CA2542880A1 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
05/12/2005CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005CA2540460A1 Heterocyclic compounds and methods of making and using thereof
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/11/2005EP1530095A2 Organophotoreceptor with charge transport material having a hydrazone group linked to an epoxy group and a heterocyclic ring
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529053A2 Macrolide compounds endowed with antiinflammatory activity
05/11/2005EP1529045A2 New compounds
05/11/2005EP1529042A1 Arylamides
05/11/2005EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
05/11/2005EP1311494B1 Continuous process for the preparation of pesticidal chlorothiazoles
05/11/2005CN1615300A Benzimidazole derivatives and their use as GNRH antagonists
05/11/2005CN1613852A Cesium triazoleamide compounds and their preparation and use
05/10/2005US6891039 2-(4-Fluorophenyl)-1-(2-cyclopentylamino-4-pyrimidinyl)-5-(piperidino-N -2-ethyl)imidazo(4,5-b)pyridine, for example; MAP kinase inhibitors, for Tumor Necrosis Factor (TNF-alpha) and Interleukin-1 (IL-1) disorders such as osteoporosis
05/10/2005US6890947 (S)-3-(1-(2-(2-chloro-phenyl)-5-methyl-oxazol-4-ylmethyl)-1H -indol-5-yl)-2-ethoxy-propionic acid; peroxisome proliferator activated receptors (PPARs)
05/10/2005US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1
05/10/2005US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/10/2005US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth
05/10/2005US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
05/10/2005CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 628